|
|
|
|
Subchronic and Chronic Toxicity
(Other than Carcinogenicity) |
|
Subchronic [RfD]: (see comment) |
5E-5 mg/kg/day |
|
Uncertainty Factor: |
100 |
|
Route: |
Oral: diet |
|
Target Organ / Critical Effect: |
Liver / Lesions |
|
Species |
Effect Level |
Dose |
Experiment Length |
Rat |
NOAEL |
0.005 mg/kg/day |
2 years |
|
References |
1969 | Walker A.I.T., D.E. Stevenson, J. Robinson, et al. 1969. The toxicology and pharmacodynamics of Dieldrin (HEOD): Two-year oral exposure of rats and dogs. Toxicol Appl Pharmacol. 15: 345-373. |
1987 | U.S. EPA. 1987. RfD/RfC Work Group. |
|
Subchronic [RfD] Comments: |
The chronic oral RfD was adopted as the subchronic oral [RfD]. |
|
|
|
|
Carcinogenicity |
|
Inhalation [Slope Factor]: (see comment) | 1.6E+1 (mg/kg/day)-1 |
|
|
Route: |
Oral: diet |
|
Target Organ / Cancer: |
Liver / Carcinoma |
|
Species |
EPA Group |
|
Mouse |
IRIS |
|
|
References |
1978 | NCI (National Cancer Institute). 1978. Bioassays of Aldrin and Dieldrin for possible carcinogenicity. National Cancer Institute Carcinogen Tech Rep Ser No. 22 NCI-CG-TR-22. Also publ as DHEW Publ No. (NIH) 78-882. |
1972 | Walker, A.I.T., E. Thorpe and D.E. Stevenson. 1972. The toxicology of Dieldrin (HEOD): I. Long-term oral toxicity studies in mice. Food Cosmet Toxicol. 11: 415-432. |
1983 | Meierhenrey, E.F., B.H. Reuber, M.E. Gershwin et al. 1983. Dieldrin induced mallory bodies in hepatic tumors of mice of different strains. Hepatology. 3: 90-95. |
1981 | Tennekes, H.A., A.S. Wright, K.M. Dix and J.H. Koeman. 1981. Effects of Dieldrin, diet and bedding on enzyme function and tumor incidence in livers of male CF-1 mice. Cancer Res. 41: 3615-3620. |
1973 | Thorpe, E. and A.I.T. Walker. 1973. The toxicology of Dieldrin (HEOD). II. Comparative long-term oral toxicity studies in mice with Dieldrin, DDT, Phenobarbitone, beta-BHC and gamma-BHC. Food Cosmet Toxicol. 11: 433-442. |
1965 | Davis, K.J. 1965. Pathology report on mice fed Aldrin, Dieldrin, Heptachlor or Hepatochlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehman, July 19. |
1987 | U.S. EPA. 1987. Health effects assessment for Dieldrin. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Emergency and Remedial Response, Washington, DC. |
1987 | U.S. EPA. 1987. Carcinogen Risk Assessment Verification Endeavor (CRAVE) Work Group. |
|
Inhalation Slope Comment: |
See Appendix A-II, Dose Conversions on HEAST. |
|